FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1742-1743 December 2, 1993 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Snyder, J. D. Related Article by Figueroa-Quintanilla, D.

To the Editor: Figueroa-Quintanilla et al. (June 10 issue)¹ state that bismuth subsalicylate could be a useful, safe, and cost-effective adjunct to oral rehydration and nutritional therapy in children with acute watery diarrhea. We are surprised that they did not consider the risk of Reye's syndrome, since the use of aspirin, a salicylate-containing drug, has been associated with an increased risk of this syndrome. Whether or not there is an increased risk of Reye's syndrome with the use of bismuth subsalicylate remains to be determined. The syndrome, however, has been reported in patients whose only exposure to salicylates was to . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.